Kei Pharma Co., Ltd.
株式会社ケイファーマ
K Pharma, Inc.
Alias
Japan
iPS Drug Discovery Business
Regenerative Medicine Business
7-7-7 Roppongi, Minato-ku, Tokyo 106-0032, Tri-Seven Roppongi 6F
Hiroaki Fukushima
17 people
Company name
Group
Parent
Subsidiary
Customer
Supplier
Alliance
Bank
Shareholder
Loading...
Loading the relationship graph...
12 entries
| Date | Description |
|---|
| 2007 |
Addressing unmet medical needs such as neurodegenerative diseases and spinal cord injuries is a societal challenge, and the rapid development of effective drugs and therapies is required. |
| 2016-11-01 |
Established Kei Pharma Co., Ltd. in Minato-ku, Tokyo, with the purpose of researching, developing, manufacturing, and selling pharmaceutical and regenerative medicine products. |
| 2016-11 |
Founded Kei Pharma Co., Ltd. together with Dr. Eiichi Okano of Keio University School of Medicine and Dr. Masaya Nakamura of the Department of Orthopedic Surgery. |
| 2018-04 |
Opened Kei Pharma Lab at Shonan Health Innovation Park (Shonan I-Park). |
| 2020-04 |
Entered into a joint research agreement with Keio University with the aim of developing pharmaceutical and regenerative medicine products using iPS cells. |
| 2022-07 |
Entered into a joint research agreement with Keio University for clinical trials of regenerative medicine using iPS cell-derived neural progenitor cells for subacute spinal cord injury. |
| 2022-11-01 |
Hiroaki Fukushima assumed the position of President and CEO of Kei Pharma Co., Ltd. |
| 2023-02 |
Established the "Kei Pharma-Keio Spinal Cord Regeneration Lab" in the Comprehensive Medical Science Research Building on Keio University's Shinano-cho campus. |
| 2023-03 |
Signed a licensing agreement with Alfressa Pharma Inc. regarding the derivation of KP2011, a candidate ALS therapeutic in Japan. |
| 2023-06 |
Entered into a joint research agreement with Kitasato Institute for clinical trials of a hearing loss therapeutic. |
| 2023-08 |
Entered into a joint research agreement with the National Hospital Organization Osaka Medical Center for clinical trials of regenerative medicine for chronic stroke, cerebral hemorrhage, and traumatic central nervous system injury. |
| 2023-10 |
Listed shares on the Tokyo Stock Exchange Growth Market. |
9010401128001
| Trade name | 株式会社ケイファーマ |
|---|
| Trade name (kana) | ケイファーマ |
|---|
| Name in English | |
|---|
| Corporation type | 301 |
|---|
| Address | 〒106-0032 東京都港区六本木７丁目７番７号 |
|---|
| Postal code | 1060032 |
|---|
| Prefecture code | 13 |
|---|
| City code | 103 |
|---|
| Address outside Japan | |
|---|
| Prefecture in English | |
|---|
| City in English | |
|---|
| Address outside Japan in English | |
|---|
| Corporate number assignment date | 2016-11-08 |
|---|
| Update date | 2018-05-09 |
|---|
| Change date | 2016-11-08 |
|---|
| Registry closure date | |
|---|
| Reason for registry closure | |
|---|
| Successor corporate number | |
|---|
| Details of the change | |
|---|
| Latest record | 1 |
|---|
| Excluded from search | 0 |
|---|
| Processing type | 01 |
|---|
| Correction type | 1 |
|---|
| Trade name image ID | |
|---|
| Address image ID | |
|---|
| Sequence number | 2493140 |
|---|
Source: National Tax Agency Corporate Number Publication Site, basic three items
9010401128001
| Corporate number | 9010401128001 |
|---|
| Trade name | 株式会社ケイファーマ |
|---|
| Trade name (kana) | ケイファーマ |
|---|
| Trade name (alphabet) | |
|---|
| Registry closure date | |
|---|
| Reason for registry closure | |
|---|
| Registered address | 東京都港区六本木７丁目７番７号 |
|---|
| Postal code | 1060032 |
|---|
| Prefecture | 東京都 |
|---|
| Prefecture code | 13 |
|---|
| City or district | 港区 |
|---|
| City code | 103 |
|---|
| Street address | 六本木７丁目７番７号 |
|---|
| Organisation type | 301 |
|---|
| Processing type | 01 |
|---|
| Correction type | 1 |
|---|
| Status | |
|---|
| Representative | 代表取締役社長 福島 弘明 |
|---|
| Capital | 10175000 |
|---|
| Employees | 20 |
|---|
| Employees (male) | |
|---|
| Employees (female) | |
|---|
| Business summary | |
|---|
| Website URL | |
|---|
| Year founded | |
|---|
| Business category | |
|---|
| Date established | |
|---|
| Unified government qualification - grade | |
|---|
| Unified government qualification - business items | |
|---|
| Update date | 2018-05-09 |
|---|
| Key information | 9010401128001 |
|---|
Source: gBizINFO (Ministry of Economy, Trade and Industry)
2026-09-23 02:55 (Model: gpt-4.1-nano )
